Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin

被引:23
|
作者
Kotecha, Dipak [1 ]
Pollack, Charles V., Jr. [1 ]
De Caterina, Raffaele [1 ]
Renda, Giulia [1 ]
Kirchhof, Paulus [1 ]
机构
[1] Univ Birmingham, Inst Cardiovasc Sci, Med Sch, Vincent Dr, Birmingham B15 2TT, W Midlands, England
基金
英国医学研究理事会;
关键词
MANAGEMENT;
D O I
10.1016/j.jacc.2018.07.083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1984 / 1986
页数:4
相关论文
共 50 条
  • [41] GERIATRIC ELEMENTS AND PRESCRIPTION OF WARFARIN VERSUS DIRECT ORAL ANTICOAGULANTS AMONG OLDER PATIENTS WITH AF: THE SAGE-AF STUDY
    Aldrugh, Summer
    Sanghai, Saket
    Waring, Molly
    Kiefe, Catarina
    Goldberg, Robert
    Gurwitz, Jerry
    Lessard, Darleen
    Parish, David
    Helm, Robert
    Sogade, Felix
    Hayward, Robert
    Mailhot, Tanya
    Barton, Bruce
    Saczynski, Jane
    McManus, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 438 - 438
  • [42] Risk of thromboembolic events after AF ablation
    Chen, Peng-Sheng
    HEART RHYTHM, 2006, 3 (11) : 1394 - 1394
  • [43] Incidence of thromboembolic events after four-factor prothrombin complex concentrate (PCC4) administration for emergent reversal of warfarin or direct oral anticoagulants in intracranial hemorrhage
    Scott, Rachael
    PHARMACOTHERAPY, 2017, 37 (12): : E149 - E150
  • [44] Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension
    Mateo Porres-Aguilar
    Marius M. Hoeper
    Belinda N. Rivera-Lebron
    Gustavo A. Heresi
    Debabrata Mukherjee
    Victor F. Tapson
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 791 - 796
  • [45] Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension
    Porres-Aguilar, Mateo
    Hoeper, Marius M.
    Rivera-Lebron, Belinda N.
    Heresi, Gustavo A.
    Mukherjee, Debabrata
    Tapson, Victor F.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (03) : 791 - 796
  • [46] New oral anticoagulants versus Warfarin in patients undergoing cardioversion of atrial fibrillation
    Ando, Giuseppe
    Trio, Olimpia
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 225 : 244 - 246
  • [47] BLEEDING RISK OF DIRECT ORAL ANTICOAGULANTS COMPARED WITH WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE
    Lu, Lingyun
    Warner, Alberta
    Ghaznavi, Zunera
    Chang, Donald
    Tubert, Nikolas
    Jackevicius, Cynthia
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 900 - 900
  • [48] Efficacy and Safety of Direct Oral Anticoagulants Compared to Warfarin in Patients with Cirrhosis and Splanchnic Vein Thrombosis
    Prince, Sean-Patrick
    Dayto, Denisse Camille
    Sephien, Andrew
    Lozano, Marc
    Tobillo, Robyn
    Hurlock, Natalie P.
    Ram, Anil
    Abernathy, John
    SOUTHERN MEDICAL JOURNAL, 2024, 117 (11) : 662 - 665
  • [49] ARTERIAL HYPERTENSION AS A PREDICTOR OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH DIRECT ORAL ANTICOAGULANTS
    Sinigoj, Petra
    Kabaklic, Amela
    Hitij, Jana Brguljan
    Mavri, Alenka
    JOURNAL OF HYPERTENSION, 2023, 41 : E90 - E90
  • [50] Direct Oral Anticoagulants in the Treatment of Venous Thromboembolic Disease
    Salmeron Febres, Luis Miguel
    Cuenca Manteca, Jorge
    ANNALS OF VASCULAR SURGERY, 2017, 42 : 337 - 350